தொடக்க நகரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from தொடக்க நகரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In தொடக்க நகரம் Today - Breaking & Trending Today
Tokyo Time indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Joint Israeli-Arab-Palestinian Tech Pitch Event Builds Bridges Of Hope Tech & Innovation Erel Margalit, JVP founder and chairman, speaks with Gazan entrepreneur Rami A. Courtesy. An eco-friendly hotel run jointly by Jews and Arabs; an educational app that teaches Hebrew and Arabic; a Jerusalem-based musical training program; and an app creating videos that depict both Jewish-Israeli and Palestinian cultures were just a few of the startup ideas and social projects pitched at a joint Israeli-Arab-Palestinian tech-pitch event held in Jerusalem last week. The “Pitch Your Bridge” event, featuring at least 60 Israeli and Palestinian entrepreneurs from Jerusalem, Gaza, Nablus, Rahat, and the United Arab Emirates, was hosted by global VC firm Jerusalem Venture Partners (JVP) at the Margalit Startup City headquarters, just a week after an 11-day round of violence between Israel and Hamas, the terror organization that rules the Gaza Strip, ended last month. ....
Search jobs 01-Jun-2021 Heartseed and Novo Nordisk enter into global collaboration and licence agreement for stem cell-based therapy for heart failure Bagsværd , Denmark and Tokyo, Japan, 1 June 2021 – Heartseed Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive worldwide collaboration and licence agreement for development, manufacturing and commercialisation of Heartseed’s lead asset HS-001. HS-001 is an investigational cell therapy using purified cardiomyocytes derived from induced pluripotent stem cells (iPSC), which is currently under development by Heartseed for the treatment of heart failure. Heartseed is planning to initiate a phase 1/2 clinical trial in Japan (LAPiS Study) in the second half of 2021 evaluating the safety and efficacy of HS-001 for the treatment of heart failure caused by ischemic heart disease. Japan’s Pharmaceutical and Medical Devices Agency h ....